BioNTech to Build Africa’s First mRNA Manufacturing Facility
Three months after the World Bank announced a EUR 600 million loan to South Africa’s Aspen Pharmacare, the African continent has received more good news as it seeks to increase…
Address: 321 Main road, La Rocca,
Office Park, building D
Bryanston 2021,South Africa
Tel: 011 463 5733
Batswadi Pharmaceuticals (Pty) Ltd. operates as a clinical research company.
Batswadi was founded by CEO, Christopher Whitfield and Hennie Visser, Batswadi (meaning parent in Tswana) aims to increase Africa’s access to innovative products, diagnostics, devices and services.
Batswadi’s strategic partnerships with key stakeholders enable it to deliver economic benefits to its shareholders while simultaneously increasing African access to innovative products and technologies.
The management team has extensive experience in launching and marketing innovative products in the South African pharmaceutical market. Their experience in the evolution of the market provides deep understanding of critical developments expected into the future.
Batswadi specializes in clinical trials from phases II, III and IV.
The company focuses on four platforms: biotechnology, pharmaceuticals, diagnostics and clinical research. We further provide innovative medical companies with a presence in Africa, as well as the required infrastructure to launch their products on the continent.
Three months after the World Bank announced a EUR 600 million loan to South Africa’s Aspen Pharmacare, the African continent has received more good news as it seeks to increase…
In a notable first, following successful pilot immunisation programmes in Ghana, Kenya and Malawi, the World Health Organization (WHO) has recommended that the RTS,S malaria vaccine be rolled out across…
A roundup of the latest news from South African pharma, including Aspen’s impressive annual growth, Adcock Ingram’s full year profit drop, and Entos Pharma’s approval for Phase II clinical rials…
With Africa struggling to vaccinate its populations against COVID-19, the World Bank – along with government institutions from the USA, Germany, and France – has intervened to loan South African…
The latest from South African pharma, including President Ramaphosa’s blunt criticism of Big Pharma, Aspen’s reception of USD 700 million in international financial aid, Adcock Ingram’s disappointing results as fewer…
South African firm Aspen has inked a deal with Johnson & Johnson for the technical transfer and proposed commercial manufacture of their COVID-19 vaccine candidate, Ad26.COV2-S, boosting the company’s share…
As COVID-19 threatens to derail more than a decade’s worth of hard-won gains in the fight against malaria, Dr Benjamin Pretorius, managing director at ERADA Technology Alliance, warns that diversions…
The South African affiliate of Indian pharma firm Cipla will begin manufacturing and distribution of remdesivir, a Covid-19 drug, in South Africa this month. The company’s priority is ensuring access…
Below is a roundup of latest news from South Africa’s life sciences and healthcare industries, including a call to overhaul patent laws to allow better access to COVID-19 drugs, innovation…
Kelly du Plessis is CEO & Founder of Rare Diseases South Africa, a registered NPO born out of necessity when her oldest child was diagnosed with Pompe disease at 11…
Trailing behind South Africa’s pharmaceutical market in both value and growth, the nation’s medical device industry has long enjoyed minimal barriers to entry and easy market access. But, with imminent…
The traditional model of healthcare has generally been limited to treatment in health facilities. But, when it comes to effectively treating more private and deeply personal health conditions, especially in…
See our Cookie Privacy Policy Here
